DE602006013151D1 - Verfahren zur herstellung von polymermaleimiden - Google Patents

Verfahren zur herstellung von polymermaleimiden

Info

Publication number
DE602006013151D1
DE602006013151D1 DE602006013151T DE602006013151T DE602006013151D1 DE 602006013151 D1 DE602006013151 D1 DE 602006013151D1 DE 602006013151 T DE602006013151 T DE 602006013151T DE 602006013151 T DE602006013151 T DE 602006013151T DE 602006013151 D1 DE602006013151 D1 DE 602006013151D1
Authority
DE
Germany
Prior art keywords
polymermalimides
producing
conjugates
maleimide
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006013151T
Other languages
English (en)
Inventor
Antoni Kozlowski
John Handley
Anthony G Schaefer
Brian Bray
Ryan Odom
Tony L Sander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nektar Therapeutics
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Publication of DE602006013151D1 publication Critical patent/DE602006013151D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/91—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/12—Unsaturated polyimide precursors
    • C08G73/121—Preparatory processes from unsaturated precursors and polyamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33331—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/12—Unsaturated polyimide precursors
DE602006013151T 2005-07-19 2006-07-19 Verfahren zur herstellung von polymermaleimiden Active DE602006013151D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70097205P 2005-07-19 2005-07-19
PCT/US2006/028271 WO2007012059A2 (en) 2005-07-19 2006-07-19 Method for preparing polymer maleimides

Publications (1)

Publication Number Publication Date
DE602006013151D1 true DE602006013151D1 (de) 2010-05-06

Family

ID=37667637

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006013151T Active DE602006013151D1 (de) 2005-07-19 2006-07-19 Verfahren zur herstellung von polymermaleimiden

Country Status (12)

Country Link
US (4) US7872082B2 (de)
EP (1) EP1915412B1 (de)
JP (1) JP5600240B2 (de)
KR (1) KR101334541B1 (de)
CN (1) CN101268118B (de)
AT (1) ATE461960T1 (de)
AU (1) AU2006269845B2 (de)
CA (1) CA2614987C (de)
DE (1) DE602006013151D1 (de)
ES (1) ES2341285T3 (de)
MX (1) MX2008000867A (de)
WO (1) WO2007012059A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2341285T3 (es) * 2005-07-19 2010-06-17 Nektar Therapeutics Metodo para preparar maleimidas polimericas.
DE102007034580B4 (de) * 2007-07-13 2012-11-08 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Biomaterial basierend auf einem hydrophilen polymeren Träger
KR100771100B1 (ko) * 2007-07-18 2007-10-29 아이디비켐(주) 고순도의 메톡시폴리에틸렌글리콜에틸말레이미드의제조방법
RU2447083C1 (ru) * 2010-07-20 2012-04-10 Закрытое Акционерное Общество "Биокад" НОВЫЙ ФУНКЦИОНАЛЬНО АКТИВНЫЙ ВЫСОКООЧИЩЕННЫЙ СТАБИЛЬНЫЙ КОНЪЮГАТ ИНТЕРФЕРОНА α С ПОЛИЭТИЛЕНГЛИКОЛЕМ, ПРЕДСТАВЛЕННЫЙ ОДНИМ ПОЗИЦИОННЫМ ИЗОМЕРОМ ПЭГ-NαH-ИФН, С УМЕНЬШЕННОЙ ИММУНОГЕННОСТЬЮ, С ПРОЛОНГИРОВАННЫМ БИОЛОГИЧЕСКИМ ДЕЙСТВИЕМ, ПРИГОДНЫЙ ДЛЯ МЕДИЦИНСКОГО ПРИМЕНЕНИЯ, И ИММУНОБИОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ
WO2012123519A2 (en) 2011-03-15 2012-09-20 Novo Nordisk A/S Human insulin analogues and derivatives comprising cysteine substitutions
US8815226B2 (en) 2011-06-10 2014-08-26 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
ES2622578T3 (es) 2011-06-10 2017-07-06 Mersana Therapeutics, Inc. Conjugados de proteína-polímero-fármaco
WO2015046163A1 (ja) * 2013-09-30 2015-04-02 株式会社フジミインコーポレーテッド 研磨用組成物およびその製造方法
AU2014331714B2 (en) 2013-10-11 2019-05-02 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
CN105813655B (zh) 2013-10-11 2022-03-15 阿萨纳生物科技有限责任公司 蛋白-聚合物-药物缀合物
US20200188476A1 (en) * 2017-04-18 2020-06-18 The Regents Of The University Of California Anti-microbial agent-polymer conjugates and methods of use thereof
AU2019209930B2 (en) 2018-01-17 2023-08-03 Magic Leap, Inc. Eye center of rotation determination, depth plane selection, and render camera positioning in display systems
WO2019143864A1 (en) 2018-01-17 2019-07-25 Magic Leap, Inc. Display systems and methods for determining registration between a display and a user's eyes
CN112689869A (zh) 2018-07-24 2021-04-20 奇跃公司 用于确定显示器与用户的眼睛之间的配准的显示系统和方法
CN112898561A (zh) * 2021-01-27 2021-06-04 大连理工大学 马来酰亚胺封端聚苯醚及其制备方法
CN114409836B (zh) * 2021-12-20 2023-05-05 中国科学院化学研究所 一种非共轭型荧光材料及其制备方法和应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2031538A1 (en) 1969-02-20 1970-11-20 Eastman Kodak Co Maleimide and its n-substd derivs prepn
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4675414A (en) 1985-03-08 1987-06-23 The United States Of America As Represented By The Secretary Of The Navy Maleimidomethyl-carbonate polyethers
US4775729A (en) 1985-03-08 1988-10-04 The United States Of America As Represented By The Secretary Of The Navy Curable polyether compositions
JPH0730021B2 (ja) 1986-03-05 1995-04-05 旭化成工業株式会社 ポリマレイミド化合物
EP0318162A3 (de) * 1987-11-25 1990-11-07 Texaco Development Corporation Bismaleinimid-Derivate
JPH02268155A (ja) 1989-04-07 1990-11-01 Teijin Ltd ペンダント水酸基含有ｎ―アルキルマレイミド類の製造方法
US5166322A (en) 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
JP2505581B2 (ja) 1989-06-12 1996-06-12 帝人株式会社 硬化性不飽和イミドウレタン組成物、その製造法及び硬化成型物
FR2653132B1 (fr) 1989-10-17 1993-06-04 Etu Materiaux Organ Techn Cent Materiaux expanses a base de resine nadimide.
US5053423A (en) 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5766897A (en) 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
WO1993024476A1 (en) 1992-06-04 1993-12-09 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
US6180134B1 (en) 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
US5629384A (en) 1994-05-17 1997-05-13 Consiglio Nazionale Delle Ricerche Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
MY114204A (en) 1994-11-15 2002-08-30 Shell Int Research A cross-linked resin
US5693609A (en) 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5585484A (en) 1995-04-19 1996-12-17 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Hemoglobin crosslinkers
NZ332234A (en) 1996-03-12 2000-06-23 Pg Txl Company Lp Water soluble paclitaxel prodrugs formed by conjugating paclitaxel or docetaxel with a polyglutamic acid polymer and use for treating cancer
US5844020A (en) 1997-03-31 1998-12-01 Xerox Corporation Phase change ink compositions
US6183738B1 (en) 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
US5990237A (en) 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
ES2307865T3 (es) 1998-03-12 2008-12-01 Nektar Therapeutics Al, Corporation Metodo para preparar conjugados polimericos.
US20040110822A1 (en) 1998-07-14 2004-06-10 The University Of Newcastle Research Associates Anhydride modified cantharidin analogues useful in the treatment of cancer
US6303119B1 (en) 1999-09-22 2001-10-16 The Procter & Gamble Company Personal care compositions containing subtilisin enzymes bound to water insoluble substrates
US6180598B1 (en) 1999-10-07 2001-01-30 Deanna J. Nelson Covalently modified hemoglobin having low temperature-dependent oxygen-binding function
US6403753B1 (en) 2000-01-18 2002-06-11 Sandia Corporation Method of making thermally removable polyurethanes
WO2001062827A2 (en) * 2000-02-22 2001-08-30 Shearwater Corporation N-maleimidyl polymer derivatives
SE0000811D0 (sv) 2000-03-13 2000-03-13 Perstorp Flooring Ab Process for the production of 2-hydroxyethylmaleimide and the production obtained by the process
EP1287404A4 (de) 2000-05-01 2003-10-15 Proligo Llc Verfahren zur immobilisierung von oligonukleotiden, welches das cycloaddition-bikonjugierungs-verfahren anwendet
US6673905B2 (en) 2000-08-09 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Conjugation of biomolecules using Diels-Alder cycloaddition
TW593427B (en) 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
JP4123856B2 (ja) 2001-07-31 2008-07-23 日油株式会社 生体関連物質の修飾剤およびポリオキシアルキレン誘導体の製造方法
US20030153491A1 (en) 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US6815078B2 (en) 2002-03-06 2004-11-09 Eastman Kodak Company Substrate for protein microarray containing functionalized polymer
US7217845B2 (en) 2002-11-25 2007-05-15 Sun Bio, Inc. Bifunctional polyethylene glycol derivatives
US7432330B2 (en) * 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
CA2509260C (en) 2002-12-31 2012-10-02 Nektar Therapeutics Al, Corporation Maleamic acid polymer derivatives and their bioconjugates
US7635734B2 (en) * 2004-02-17 2009-12-22 The Children's Hospital Of Philadelphia Photochemical activation of surfaces for attaching biomaterial
KR100512483B1 (ko) 2003-05-07 2005-09-05 선바이오(주) 신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법
US7790835B2 (en) 2003-12-03 2010-09-07 Nektar Therapeutics Method of preparing maleimide functionalized polymers
ES2341285T3 (es) 2005-07-19 2010-06-17 Nektar Therapeutics Metodo para preparar maleimidas polimericas.

Also Published As

Publication number Publication date
JP5600240B2 (ja) 2014-10-01
KR20080027878A (ko) 2008-03-28
ATE461960T1 (de) 2010-04-15
US7872082B2 (en) 2011-01-18
US20120022220A1 (en) 2012-01-26
MX2008000867A (es) 2008-04-04
US20120271000A1 (en) 2012-10-25
CN101268118B (zh) 2012-09-19
US20110046315A1 (en) 2011-02-24
CN101268118A (zh) 2008-09-17
AU2006269845B2 (en) 2012-03-22
EP1915412B1 (de) 2010-03-24
US20070049688A1 (en) 2007-03-01
KR101334541B1 (ko) 2013-11-28
ES2341285T3 (es) 2010-06-17
WO2007012059A2 (en) 2007-01-25
WO2007012059A3 (en) 2007-05-03
CA2614987C (en) 2013-10-08
AU2006269845A1 (en) 2007-01-25
JP2009503150A (ja) 2009-01-29
EP1915412A2 (de) 2008-04-30
US8227558B2 (en) 2012-07-24
US8058385B2 (en) 2011-11-15
CA2614987A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
DE602006013151D1 (de) Verfahren zur herstellung von polymermaleimiden
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
DE602006015090D1 (de) Verfahren zur herstellung von gezielt durchlässigen laminaten
ATE443038T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid
ATE497984T1 (de) Dimercaptanterminierte polythioetherpolymere und verfahren zu ihrer herstellung und verwendung
ATE516816T1 (de) Verfahren zur herstellung von impfstoffen
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
ATE449096T1 (de) Verfahren zur herstellung von 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-p enoxypropyl)-1- azoniabicycloä2.2.2üoctanbromid
ATE465277T1 (de) Verfahren zur herstellung von leder
DE502005003004D1 (de) Verfahren zur herstellung von polycarbonat
DE502006002510D1 (de) Verfahren zur herstellung von silikon-haltigen polymerisaten
DE602006018484D1 (de) Verfahren zur herstellung von phosphatpolymer
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
ATE549314T1 (de) Verfahren zur herstellung von 4-aminochinazolinen
DE602005011814D1 (de) Verfahren zur herstellung von enantiomerreinen 1,1'-spirobiindan-6,6'-diol-derivaten
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
ATE430140T1 (de) Verfahren zur herstellung von ä1,4,5ü- oxadiazepinderivaten
DE502006002680D1 (de) Verfahren zur herstellung von feinteiligem c.i. pigment red 254
DE602006013623D1 (de) Verfahren zur herstellung von fluorhaltigem polymer
DE502005003098D1 (de) Verfahren zur herstellung von polycarbonat

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NEKTAR THERAPEUTICS, SAN CARLOS, CALIF., US

8364 No opposition during term of opposition